BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 16242998)

  • 1. Activation of refractory T cell responses against hepatitis C virus core protein by ablation of interfering hydrophobic domains.
    Andersson HA; Singh RA; Barry MA
    Mol Ther; 2006 Feb; 13(2):338-46. PubMed ID: 16242998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Enhancement of cellular immune response to DNA vaccine encoding hepatitis C virus core and envelope 2 fusion antigen by murine Fms-like tyrosine kinase 3 ligand].
    Ke JS; Zhao P; Cao J; Yu JP; Qi ZT
    Sheng Wu Gong Cheng Xue Bao; 2003 Mar; 19(2):158-62. PubMed ID: 15966314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids.
    Geissler M; Gesien A; Tokushige K; Wands JR
    J Immunol; 1997 Feb; 158(3):1231-7. PubMed ID: 9013964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel combined vaccine candidate containing epitopes of HCV NS3, core and E1 proteins induces multi-specific immune responses in BALB/c mice.
    Zeng R; Li G; Ling S; Zhang H; Yao Z; Xiu B; He F; Huang R; Wei L
    Antiviral Res; 2009 Oct; 84(1):23-30. PubMed ID: 19646486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic immunization of wild-type and hepatitis C virus transgenic mice reveals a hierarchy of cellular immune response and tolerance induction against hepatitis C virus structural proteins.
    Satoi J; Murata K; Lechmann M; Manickan E; Zhang Z; Wedemeyer H; Rehermann B; Liang TJ
    J Virol; 2001 Dec; 75(24):12121-7. PubMed ID: 11711603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and immune response to hepatitis C virus core DNA-based vaccine constructs.
    Tokushige K; Wakita T; Pachuk C; Moradpour D; Weiner DB; Zurawski VR; Wands JR
    Hepatology; 1996 Jul; 24(1):14-20. PubMed ID: 8707253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus (HCV) core protein enhances the immunogenicity of a co-delivered DNA vaccine encoding HCV structural antigens in mice.
    Alvarez-Lajonchere L; González M; Alvarez-Obregón JC; Guerra I; Viña A; Acosta-Rivero N; Musacchio A; Morales J; Dueñas-Carrera S
    Biotechnol Appl Biochem; 2006 Apr; 44(Pt 1):9-17. PubMed ID: 16367740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elimination of immunodominant epitopes from multispecific DNA-based vaccines allows induction of CD8 T cells that have a striking antiviral potential.
    Riedl P; Wieland A; Lamberth K; Buus S; Lemonnier F; Reifenberg K; Reimann J; Schirmbeck R
    J Immunol; 2009 Jul; 183(1):370-80. PubMed ID: 19542448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of immunization in mice with recombinant DNA encoding the hepatitis C virus structural protein.
    Dou J; Liu K; Chen Z; Wo J; He N; Liu Y; Zhang M; Wang X; Xu C
    Chin Med J (Engl); 1999 Nov; 112(11):1036-9. PubMed ID: 11721468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of hepatitis C virus-specific cytotoxic T lymphocytes in mice by an intrahepatic inoculation with an expression plasmid.
    Kamei A; Tamaki S; Taniyama H; Takamura S; Nishimura Y; Kagawa Y; Uno-Furuta S; Kaito M; Kim G; Toda M; Matsuura Y; Miyamura T; Adachi Y; Yasutomi Y
    Virology; 2000 Jul; 273(1):120-6. PubMed ID: 10891414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CpG immuno-stimulatory motifs enhance humoral immune responses against hepatitis C virus core protein after DNA-based immunization.
    Encke J; zu Putlitz J; Stremmel W; Wands JR
    Arch Virol; 2003 Mar; 148(3):435-48. PubMed ID: 12607097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory effects of chronic ethanol consumption on cellular immune responses to hepatitis C virus core protein are reversed by genetic immunizations augmented with cytokine-expressing plasmids.
    Geissler M; Gesien A; Wands JR
    J Immunol; 1997 Nov; 159(10):5107-13. PubMed ID: 9366440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective vaccination with hepatitis C virus NS3 but not core antigen in a novel mouse challenge model.
    El-Gogo S; Staib C; Lasarte JJ; Sutter G; Adler H
    J Gene Med; 2008 Feb; 10(2):177-86. PubMed ID: 18076128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of host immune response by the core protein of hepatitis C virus: possible implications for hepatitis C virus persistence.
    Large MK; Kittlesen DJ; Hahn YS
    J Immunol; 1999 Jan; 162(2):931-8. PubMed ID: 9916717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting of hepatitis C virus core protein for MHC I or MHC II presentation does not enhance induction of immune responses to DNA vaccination.
    Vidalin O; Tanaka E; Spengler U; Trépo C; Inchauspé G
    DNA Cell Biol; 1999 Aug; 18(8):611-21. PubMed ID: 10463057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterisation of a panel of monoclonal antibodies raised against recombinant HCV core protein.
    Ferns RB; Tuke PW; Sweenie CH
    J Med Virol; 1996 Nov; 50(3):221-9. PubMed ID: 8923286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression and immune response to hepatitis C virus core gene combined hepatitis B virus core gene with two multiple cloning sites vector].
    Deng T; Fan G; Chen T; Chen N; Hu D; Wang M; Jia K
    Zhonghua Yi Xue Za Zhi; 2002 Jan; 82(2):77-80. PubMed ID: 11953132
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole recombinant yeast-based immunotherapy induces potent T cell responses targeting HCV NS3 and Core proteins.
    Haller AA; Lauer GM; King TH; Kemmler C; Fiolkoski V; Lu Y; Bellgrau D; Rodell TC; Apelian D; Franzusoff A; Duke RC
    Vaccine; 2007 Feb; 25(8):1452-63. PubMed ID: 17098335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Core protein domains involved in hepatitis C virus-like particle assembly and budding at the endoplasmic reticulum membrane.
    Hourioux C; Ait-Goughoulte M; Patient R; Fouquenet D; Arcanger-Doudet F; Brand D; Martin A; Roingeard P
    Cell Microbiol; 2007 Apr; 9(4):1014-27. PubMed ID: 17257269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of immune responses induced by recombinant attenuated Salmonella typhi carrying eukaryotic expression plasmid or prokaryotic expression plasmid of HCV core protein].
    Chen ZH; Zhao P; Wu SM; Cao J; Zhang B; Wan MB; Ke JS; Qi ZT
    Sheng Wu Gong Cheng Xue Bao; 2007 Sep; 23(5):862-6. PubMed ID: 18051866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.